HALOBETASOL PROPIONATE Recall D-0689-2022
Description: Halobetasol Propionate Ointment, 0.05%, packaged as a) 15 g tubes, NDC 52565-073-15; b) 50 g tubes, NDC 52565-073-51, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.
HALOBETASOL PROPIONATE Recall D-0689-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0689-2022 |
Event ID | 89798 |
Brand | HALOBETASOL PROPIONATE |
Generic Name | HALOBETASOL PROPIONATE |
Manufacturer | HALOBETASOL PROPIONATE |
Original Package? | 1 |
Active Substance | HALOBETASOL PROPIONATE |
Drug Route | TOPICAL |
Distribution | Nationwide in the USA and Puerto Rico |
Quantity | 161,331 tubes |
Recall Reason | cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. |
Drug Classification | Class II |
Drug Code Info | 20220330 |
Product NDC | 52565-073 |
Recall Initiation Date | 20220315 |
Report Date | 20220330 |
Classification Date | 20220321 |
Address | 105 Lincoln Avenue Buena, NJ 08310 United States |
Recalling Firm | Teligent Pharma, Inc. |
Initial Notification | Letter |
Unique Ingredient Identifier | 91A0K1TY3Z |
Drug Application Number | ANDA209978 |
Structured Product Labeling (SPL ID) | 35da6f20-71cb-4679-8dca-bfd561b4c9fd |
Structured Product Labeling (SPL Set ID) | 102dd731-6f73-458f-9d95-9cdf14a5df06 |
Similar To |